UGM Epidemiologist Experts Ask Residents Not to Ignore Prokes After Vaccination

KOMPAS.com – The Indonesian government has initiated a vaccination program to reduce the spread of transmission Covid-19 since Wednesday (13/1/2021). Later on, the community can take turns to get vaccine injections Sinovac.

Government efforts to provide services vaccine This is of course to reduce the number of Covid-19 transmission. However, that does not mean that after receiving the vaccine, they are ignored health protocol. Like, not using a mask to not keep distance.

Because, someone who gets a vaccine injection is not completely immune to the virus immediately.

From the analysis of the Gajah Mada University Epidemiologist Expert ( UGM) Bayu Satria, the body of a person who has received a vaccine also needs time for his immune system to develop.

Also read: UGM Experts Ask The Community Not To Question The Legalization Of Sinovac Vaccines

“Because, after being injected, the protection by vaccines is not 100 percent immediately immune to the virus. For that, we still adhere to health protocols. However, at least those who have been vaccinated have a very low risk of contracting it. covid which is severe, “he said as quoted from the UGM website, Friday (15/1/2021).

He explained, vaccine injection sinovac this needs to be done twice as much. “Because the new vaccine provides the best protection around 1-2 weeks after the second injection. What is certain is that we should still take care of ourselves after the injection. Because, it can still be affected if immunity has not been formed,” he said.

Regarding the Sinovac vaccine, which has not prioritized the groups of children and the elderly over the age of 59 years, Bayu believes that these two groups will receive vaccine injections.

With a note, this group can get a vaccine injection when the data from the test results are complete.

“When the data obtained is more detailed, vaccines for the elderly and children will also be given. We are still waiting for more complete data,” he said.

Also read: Students, Know the Difference between Vaccines and Immunizations

He also touched on criticism from netizens who still questioned Sinovac’s level of efficacy.

Many netizens consider this type of Sinovac vaccine to be considered low compared to other types of vaccines and are considered unsafe to inject.

Previously, Indonesia conducted a third phase clinical trial of the Sinovac vaccine. From the results of the third phase clinical trial in Bandung, the efficacy of this vaccine reached 65.3 percent.

Bayu considered the Sinovac vaccine, including the type of vaccine with the best safety level.

“It is still quite good because it still provides double or more protection and is also supported by a temporary efficacy result in Indonesia of around 65 percent. The most important choice of vaccines is safety, new efficacy and Sinovac is one of the best in safety,” he concluded.

Also read: Use of 95 Percent Masks, Unpad Experts: The Covid-19 Rate Could Decrease

– .